ADCT, CRT indication agreements to develop ADCs against cancer Cancer Research Technology , the business arm of Cancer Study UK, and Switzerland-centered ADC Therapeutics Sarl announce today that they have signed agreements to build up cancer treatments called Antibody Drug Conjugates using CRT antibodies and peptides, and ADCT’s ‘warhead’ and linker chemistries. ADCs are an exciting and clinically important course of oncology medicines as they combine the specificity of antibodies with novel ‘warhead’ chemistries. The antibody component targets the malignancy cells to deliver tumour-destroying chemical substances which are internalised into the cancer tumor cell while avoiding damage to healthy tissue.What are the new methods to quality to achieve world-class manufacturing performance? How can you introduce innovation and continual improvement into production successfully? Continuing pressures on lifestyle sciences manufacturing, from elevated competition to regulatory requirements, are forcing businesses to achieve tighter working efficiencies, while enhancing their ability to fulfill quality compliance standards. Leading Pharma companies are now seeking to Lean Production and Six Sigma principles to help them increase operational efficiency and improve quality.